Approvals/TGA/ACRIS Once-a-Month risedronate sodium (as hemipentahydrate) 150 mg film-coated tablet blister pack

Approved

STANDARD

ACRIS Once-a-Month risedronate sodium (as hemipentahydrate) 150 mg film-coated tablet blister pack

Bafna Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 3faa8dbe2315df4b
Product Name: ACRIS Once-a-Month risedronate sodium (as hemipentahydrate) 150 mg film-coated tablet blister pack
Artg Id: 196060
Artg Name: ACRIS Once-a-Month risedronate sodium (as hemipentahydrate) 150 mg film-coated tablet blister pack
Sponsor: Bafna Pharmaceuticals Pty Ltd
Company Detail Path: /organization/bafna-pharmaceuticals-pty-ltd
Artg Date: 2013-02-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

3faa8dbe2315df4b

Type

Standard